172 related articles for article (PubMed ID: 36600054)
1. [Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].
Leipe J; Schmelz R; Riemekasten G; Thaçi D; Henes J; Schäkel K; Pinter A; Sticherling M; Wegner J; Fusco S; Linke M; Weber V; Manz KC; Bartz H; Roecken M; Schmidt S; Hoyer BF
Z Rheumatol; 2024 Apr; 83(3):200-209. PubMed ID: 36600054
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care].
Riemekasten G; Schmelz R; Schäkel K; Thaci D; Schreiber S; Röcken M; Bartz H; Ploner T; Liao X; Weber V; Manz KC; Burkhardt H; Leipe J
Z Rheumatol; 2023 Dec; ():. PubMed ID: 38071271
[TBL] [Abstract][Full Text] [Related]
3. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.
Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L
Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.
Menegatti S; Bianchi E; Rogge L
Front Immunol; 2019; 10():382. PubMed ID: 30941119
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
J Rheumatol; 2022 May; 49(5):523-530. PubMed ID: 35105713
[TBL] [Abstract][Full Text] [Related]
7. Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.
Shukla P; Russell MW; Muste JC; Shaia JK; Kumar M; Nowacki AS; Hajj-Ali RA; Singh RP; Talcott KE
Ophthalmol Retina; 2024 Feb; ():. PubMed ID: 38320691
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project.
Spini A; L'Abbate L; Ingrasciotta Y; Pellegrini G; Carollo M; Ientile V; Leoni O; Zanforlini M; Ancona D; Stella P; Cavazzana A; Scapin A; Lopes S; Belleudi V; Trifirò G
Clin Epidemiol; 2024; 16():395-407. PubMed ID: 38854895
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study.
Ramírez E; Romero-Jiménez R; Hernández-Muniesa B; Fernández-Pacheco M; Calvo A; Chamorro-de-Vega E; Herrero N; Úbeda B; Morell A; Ais-Larisgoitia A; Lobato-Matilla E; Muñoz Á; Casado A; Casado MÁ; Escudero-Vilaplana V
J Clin Pharm Ther; 2022 Dec; 47(12):2020-2029. PubMed ID: 35929568
[TBL] [Abstract][Full Text] [Related]
10. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002.
Robinson D; Hackett M; Wong J; Kimball AB; Cohen R; Bala M;
Curr Med Res Opin; 2006 May; 22(5):989-1000. PubMed ID: 16709321
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.
Merola JF; Ertmer B; Liang H; Yue X; Ofori S; Krueger W
J Am Acad Dermatol; 2024 May; 90(5):935-944. PubMed ID: 38147900
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
Galloway J; Barrett K; Irving P; Khavandi K; Nijher M; Nicholson R; de Lusignan S; Buch MH
RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994362
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of ten Immune-mediated inflammatory diseases (IMID) in Spain].
Puig L; Ruiz de Morales JG; Dauden E; Andreu JL; Cervera R; Adán A; Marsal S; Escobar C; Hinojosa J; Palau J; Arraiza A; Casado P; Codesido M; Pascual C; Saldaña R; Gil Á
Rev Esp Salud Publica; 2019 Mar; 93():. PubMed ID: 30907380
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.
Rizzello F; Olivieri I; Armuzzi A; Ayala F; Bettoli V; Bianchi L; Cimino L; Costanzo A; Cristaudo A; D'Angelo S; Daperno M; Fostini AC; Galeazzi M; Gilio M; Gionchetti P; Gisondi P; Lubrano E; Marchesoni A; Offidani A; Orlando A; Pugliese D; Salvarani C; Scarpa R; Vecchi M; Girolomoni G
Adv Ther; 2018 Apr; 35(4):545-562. PubMed ID: 29516409
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression.
Gwinnutt JM; Toyoda T; Barraclough M; Verstappen SMM; Hornberger M; MacGregor A
Semin Arthritis Rheum; 2023 Feb; 58():152131. PubMed ID: 36527929
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
18. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
19. ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.
Kolios AGA; Hueber AJ; Michetti P; Mrowietz U; Mustak-Blagusz M; Sator PG; Reinshagen M; Wilsmann-Theis D; Gomis-Kleindienst S; Luckey U; Rössler A; Schiefke I
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):234-241. PubMed ID: 29998520
[TBL] [Abstract][Full Text] [Related]
20. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
